Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Csaba P Kovesdy

Showing results (31-40 of 636) with videos related to

Pageof 64
Sort By:
Mayo Clinic Proceedings|February 13, 2026
Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the "Omics" Era: Gut and BeyondKeiichi Sumida, Csaba P Kovesdy
Seminars in Dialysis|November 6, 2018
Introduction to treatment considerations in conventional hemodialysis - What we knowKeiichi Sumida, Csaba P Kovesdy
Seminars in Nephrology|April 16, 2017
Disease Trajectories Before ESRD: Implications for Clinical ManagementKeiichi Sumida, Csaba P Kovesdy
Diabetes Care|June 23, 2016
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!Kamyar Kalantar-Zadeh, Csaba P Kovesdy
American Journal of Physiology. Renal Physiology|February 12, 2016
FGF23 from bench to bedsideCsaba P Kovesdy, L Darryl Quarles
Seminars in Nephrology|January 6, 2009
Why is protein-energy wasting associated with mortality in chronic kidney disease?Csaba P Kovesdy, Kamyar Kalantar-Zadeh
Current Cardiology Reports|July 25, 2016
Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational StudiesElvira O Gosmanova, Csaba P Kovesdy
Seminars in Dialysis|January 10, 2014
Restricting kidney transplant wait-listing for obese patients: let's stop defending the indefensibleCsaba P Kovesdy, Miklos Z Molnar
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2007
Serum phosphorus and the risk of progression of chronic kidney diseaseCsaba P Kovesdy, Kamyar Kalantar-Zadeh
Advances in Chronic Kidney Disease|February 24, 2009
Emerging challenges of anemia management in CKDCsaba P Kovesdy, Kamyar Kalantar-Zadeh
Pageof 64

Showing results (31-40 of 636) with videos related to

Sort By:
Pageof 64
Mayo Clinic Proceedings|February 13, 2026
Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the "Omics" Era: Gut and BeyondKeiichi Sumida, Csaba P Kovesdy
Seminars in Dialysis|November 6, 2018
Introduction to treatment considerations in conventional hemodialysis - What we knowKeiichi Sumida, Csaba P Kovesdy
Seminars in Nephrology|April 16, 2017
Disease Trajectories Before ESRD: Implications for Clinical ManagementKeiichi Sumida, Csaba P Kovesdy
Diabetes Care|June 23, 2016
Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!Kamyar Kalantar-Zadeh, Csaba P Kovesdy
American Journal of Physiology. Renal Physiology|February 12, 2016
FGF23 from bench to bedsideCsaba P Kovesdy, L Darryl Quarles
Seminars in Nephrology|January 6, 2009
Why is protein-energy wasting associated with mortality in chronic kidney disease?Csaba P Kovesdy, Kamyar Kalantar-Zadeh
Current Cardiology Reports|July 25, 2016
Blood Pressure Targets in CKD: Lessons Learned from SPRINT and Previous Observational StudiesElvira O Gosmanova, Csaba P Kovesdy
Seminars in Dialysis|January 10, 2014
Restricting kidney transplant wait-listing for obese patients: let's stop defending the indefensibleCsaba P Kovesdy, Miklos Z Molnar
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 28, 2007
Serum phosphorus and the risk of progression of chronic kidney diseaseCsaba P Kovesdy, Kamyar Kalantar-Zadeh
Advances in Chronic Kidney Disease|February 24, 2009
Emerging challenges of anemia management in CKDCsaba P Kovesdy, Kamyar Kalantar-Zadeh
Pageof 64